Discontinued Operations (Tables)

12 Months Ended

Sep. 30, 2014

Discontinued Operations and Disposal Groups [Abstract]

Operating Results from Discontinued Operations

The following is a summary of the operating results of SurModics Pharmaceuticals discontinued operations for the years ended September 30 (in thousands):

	2014			2013			2012
Total revenue	$	—		$	—		$	5,297
(Loss) income from discontinued operations	$	(260	)	$	1,136		$	2,309
Income tax benefit (provision)		84			(548	)		(1,133	)
(Loss) income from discontinued operations, net of income taxes	$	(176	)	$	588		$	1,176
Loss on sale of discontinued operations	$	—		$	—		$	(1,691	)
Income tax benefit		—			—			617
Loss on sale of discontinued operations, net of income taxes	$	—		$	—		$	(1,074	)

Assets and Liabilities of Discontinued Operations

The major classes of assets and liabilities of discontinued operations as of September 30 were as follows (in thousands):

	2014		2013
Other current assets	$	16	$	46
Current assets of discontinued operations		16		46
Total assets of discontinued operations	$	16	$	46
Other current liabilities	$	45	$	139
Current liabilities of discontinued operations		45		139
Total liabilities of discontinued operations	$	45	$	139